{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:42:55Z","timestamp":1791614575991,"version":"4.3.4"},"reference-count":75,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1136\/thoraxjnl-2015-207245","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T09:47:37Z","timestamp":1444816057000},"page":"1070-1077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":63,"title":["A systematic review and meta-analysis of the efficacy and safety of<i>N<\/i>-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB"],"prefix":"10.1136","volume":"70","author":[{"given":"Katharina","family":"Kranzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael F","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Drobniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,9,7]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2015-207245-1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(98)00108-3","article-title":"Polyamine-like actions of aminoglycosides and aminoglycoside derivatives at NMDA receptors","volume":"347","author":"Segal","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ijporl.2011.09.027","article-title":"Calcium imaging in gentamicin ototoxicity: increased intracellular calcium relates to oxidative stress and late apoptosis","volume":"75","author":"Chang","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-3","first-page":"2284","article-title":"Inner ear hair cell regeneration: A look from the past to the future","volume":"8","author":"Santaolalla","year":"2013","journal-title":"Neural Regen Res"},{"key":"key-10.1136\/thoraxjnl-2015-207245-4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr Pharm Des"},{"key":"key-10.1136\/thoraxjnl-2015-207245-5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","article-title":"Permanent gentamicin vestibulotoxicity","volume":"25","author":"Black","year":"2004","journal-title":"Otol Neurotol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-6","volume-title":"Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update","year":"2011"},{"key":"key-10.1136\/thoraxjnl-2015-207245-7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1183\/09031936.00044812","article-title":"Hearing loss in patients on treatment for drug-resistant tuberculosis","volume":"40","author":"Seddon","year":"2012","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207245-8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dkr221","article-title":"Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice","volume":"66","author":"Sturdy","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/thoraxjnl-2015-207245-10","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"key":"key-10.1136\/thoraxjnl-2015-207245-11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MOO.0b013e3282efa641","article-title":"Auditory research involving antioxidants","volume":"15","author":"Darrat","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"key-10.1136\/thoraxjnl-2015-207245-12","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1046\/j.1523-1755.2000.00437.x","article-title":"Protection from ototoxicity of intraperitoneal gentamicin in guinea pig","volume":"58","author":"Sinswat","year":"2000","journal-title":"Kidney Int"},{"key":"key-10.1136\/thoraxjnl-2015-207245-13","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMc053428","article-title":"Aspirin to prevent gentamicin-induced hearing loss","volume":"354","author":"Sha","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2015-207245-14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.ki.5002295","article-title":"Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine","volume":"72","author":"Feldman","year":"2007","journal-title":"Kidney Int"},{"key":"key-10.1136\/thoraxjnl-2015-207245-15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1525-139X.2012.01090.x","article-title":"N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients","volume":"25","author":"Feldman","year":"2012","journal-title":"Semin Dial"},{"key":"key-10.1136\/thoraxjnl-2015-207245-16","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1093\/ndt\/gfr211","article-title":"Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis","volume":"26","author":"Tokgoz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.1136\/thoraxjnl-2015-207245-17","article-title":"Preventing amikacin related ototoxicity with N-acetylcysteine in patients undergoing peritoneal dialysis","author":"Kocyigit","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.annemergmed.2009.05.010","article-title":"Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning","volume":"54","author":"Yarema","year":"2009","journal-title":"Ann Emerg Med"},{"key":"key-10.1136\/thoraxjnl-2015-207245-19","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2215\/CJN.11161012","article-title":"Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial","volume":"8","author":"Weisbord","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/00016480601110188","article-title":"Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration","volume":"127","author":"Bielefeld","year":"2007","journal-title":"Acta Oto-Laryngologica"},{"key":"key-10.1136\/thoraxjnl-2015-207245-21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/1463-1741.64972","article-title":"Dosing study on the effectiveness of salicylate\/N-acetylcysteine for prevention of noise-induced hearing loss","volume":"12","author":"Coleman","year":"2010","journal-title":"Noise Health"},{"key":"key-10.1136\/thoraxjnl-2015-207245-22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.heares.2012.01.013","article-title":"Antioxidant treatment reduces blast-induced cochlear damage and hearing loss","volume":"285","author":"Ewert","year":"2012","journal-title":"Hear Res"},{"key":"key-10.1136\/thoraxjnl-2015-207245-23","first-page":"BR159","article-title":"Different strategies in treating noise-induced hearing loss with N-acetylcysteine","volume":"14","author":"Lorito","year":"2008","journal-title":"Med Sci Monit"},{"key":"key-10.1136\/thoraxjnl-2015-207245-24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.heares.2010.07.005","article-title":"N-Acetyl-cysteine against noise-induced temporary threshold shift in male workers","volume":"269","author":"Lin","year":"2010","journal-title":"Hear Res"},{"key":"key-10.1136\/thoraxjnl-2015-207245-25","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1002\/lary.24360","article-title":"Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients","volume":"124","author":"Yoo","year":"2014","journal-title":"Laryngoscope"},{"key":"key-10.1136\/thoraxjnl-2015-207245-26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/COC.0b013e31822e006d","article-title":"Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy","volume":"36","author":"Riga","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-27","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key-10.1136\/thoraxjnl-2015-207245-28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650802665587","article-title":"Adverse reactions associated with acetylcysteine.","volume":"47","author":"Sandilands","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"key-10.1136\/thoraxjnl-2015-207245-29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-0496(200001)29:1<1::AID-PPUL1>3.0.CO;2-1","article-title":"Randomized controlled trials in cystic fibrosis (1966\u20131997) categorized by time, design, and intervention","volume":"29","author":"Cheng","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"(2)","key":"key-10.1136\/thoraxjnl-2015-207245-30","first-page":"CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/1516-4446-2013-1244","article-title":"Systematic review of N-acetylcysteine in the treatment of addictions","volume":"36","author":"Asevedo","year":"2014","journal-title":"Revista Brasileira De Psiquiatria"},{"key":"key-10.1136\/thoraxjnl-2015-207245-32","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"(6)","key":"key-10.1136\/thoraxjnl-2015-207245-33","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","author":"van Dalen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-34","first-page":"CD007662","article-title":"Pharmacotherapy for trichotillomania","volume":"11","author":"Rothbart","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-35","first-page":"CD005228","article-title":"Interventions for preventing neuropathy caused by cisplatin and related compounds","volume":"3","author":"Albers","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-36","first-page":"CD007807","article-title":"Antioxidants for female subfertility","volume":"8","author":"Showell","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-37","first-page":"CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"8","author":"Poole","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.rmed.2013.11.007","article-title":"Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials","volume":"108","author":"Atkins","year":"2014","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2015-207245-39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15412550600977361","article-title":"N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. [Review] [38 refs]","volume":"3","author":"Sutherland","year":"2006","journal-title":"COPD"},{"key":"key-10.1136\/thoraxjnl-2015-207245-40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ppul.20693","article-title":"Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. [Review] [93 refs]","volume":"42","author":"Boogaard","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2007.01.005","article-title":"Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials","volume":"33","author":"Block","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09059180.00010903","article-title":"Recent clinical trials in idiopathic pulmonary fibrosis and the BUILD-1 study","volume":"17","author":"Brown","year":"2008","journal-title":"Eur Respir Rev"},{"key":"key-10.1136\/thoraxjnl-2015-207245-43","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1378\/chest.13-0490","article-title":"Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis","volume":"144","author":"Yancy","year":"2013","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2015-207245-44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.2011.341","article-title":"Antioxidant therapy in hemodialysis patients: a systematic review","volume":"81","author":"Coombes","year":"2012","journal-title":"Kidney Int"},{"key":"key-10.1136\/thoraxjnl-2015-207245-45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"key-10.1136\/thoraxjnl-2015-207245-46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clinical Ther"},{"key":"key-10.1136\/thoraxjnl-2015-207245-47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.1999.tb01265.x","article-title":"Systematic review of N-acetylcysteine in cystic fibrosis","volume":"88","author":"Duijvestijn","year":"1999","journal-title":"Acta Paediatrica"},{"key":"key-10.1136\/thoraxjnl-2015-207245-48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/bmb\/ldp050","article-title":"The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD)","volume":"93","author":"Davies","year":"2010","journal-title":"Br Med Bull"},{"key":"key-10.1136\/thoraxjnl-2015-207245-49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease","volume":"5","author":"Mecocci","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key-10.1136\/thoraxjnl-2015-207245-50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"key-10.1136\/thoraxjnl-2015-207245-51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/NDT.S43419","article-title":"Mood disorders and complementary and alternative medicine: a literature review","volume":"9","author":"Qureshi","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key-10.1136\/thoraxjnl-2015-207245-52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00001648-200105000-00005","article-title":"Low P-values or narrow confidence intervals: which are more durable?","volume":"12","author":"Poole","year":"2001","journal-title":"Epidemiology"},{"key":"key-10.1136\/thoraxjnl-2015-207245-53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1440-1819.2012.02392.x","article-title":"Effects of N-acetyl cysteine on cognitive function in bipolar disorder","volume":"66","author":"Dean","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"key":"key-10.1136\/thoraxjnl-2015-207245-54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.clnu.2013.04.007","article-title":"Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review","volume":"32","author":"Schloss","year":"2013","journal-title":"Clin Nutr"},{"key":"key-10.1136\/thoraxjnl-2015-207245-55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207245-56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr Bull"},{"key":"key-10.1136\/thoraxjnl-2015-207245-57","first-page":"351","article-title":"Effect of high\/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Shen","year":"2014","journal-title":"COPD"},{"key":"key-10.1136\/thoraxjnl-2015-207245-58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Inst Stat Math"},{"key":"key-10.1136\/thoraxjnl-2015-207245-59","first-page":"138","article-title":"The inverse of the Freeman-Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am Stat"},{"key":"key-10.1136\/thoraxjnl-2015-207245-60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2015-207245-61","doi-asserted-by":"crossref","first-page":"e40781","DOI":"10.1371\/journal.pone.0040781","article-title":"Adverse events among HIV\/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India","volume":"7","author":"Isaakidis","year":"2012","journal-title":"PLoS ONE"},{"key":"key-10.1136\/thoraxjnl-2015-207245-62","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5588\/ijtld.12.0537","article-title":"Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis","volume":"17","author":"Toczek","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/crj.12044","article-title":"Risk factors for extensively drug-resistant tuberculosis: a review","volume":"8","author":"Flor de Lima","year":"2014","journal-title":"Clin Respir J"},{"key":"key-10.1136\/thoraxjnl-2015-207245-65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.5588\/ijtld.11.0696","article-title":"Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002\u20132005","volume":"16","author":"Cavanaugh","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-66","doi-asserted-by":"crossref","first-page":"e110461","DOI":"10.1371\/journal.pone.0110461","article-title":"Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India","volume":"9","author":"Isaakidis","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.1136\/thoraxjnl-2015-207245-67","doi-asserted-by":"crossref","first-page":"24912","DOI":"10.3402\/gha.v7.24912","article-title":"HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide","volume":"7","author":"Das","year":"2014","journal-title":"Glob Health Action"},{"key":"key-10.1136\/thoraxjnl-2015-207245-68","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/MJT.0b013e3181c0806d","article-title":"Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran","volume":"18","author":"Baghaei","year":"2011","journal-title":"Am J Ther"},{"key":"key-10.1136\/thoraxjnl-2015-207245-69","article-title":"Adverse events associated with the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis","author":"Wu","journal-title":"Am J Ther"},{"key":"key-10.1136\/thoraxjnl-2015-207245-70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MEG.0b013e3283426775","article-title":"Protective effect of N-acetyl cysteine on antituberculosis drug-induced hepatotoxicity","volume":"23","author":"Baniasadi","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.1136\/thoraxjnl-2015-207245-71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-14-2","article-title":"Results from early programmatic implementation of Xpert MTB\/RIF testing in nine countries","volume":"14","author":"Creswell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2471\/BLT.13.122028","article-title":"Principles for designing future regimens for multidrug-resistant tuberculosis","volume":"92","author":"Brigden","year":"2014","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/thoraxjnl-2015-207245-73","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(12)61080-0","article-title":"14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial","volume":"380","author":"Diacon","year":"2012","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2015-207245-74","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.14.0100","article-title":"Successful \u20189-month Bangladesh regimen\u2019 for multidrug-resistant tuberculosis among over 500 consecutive patients","volume":"18","author":"Aung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-207245-75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1745-6215-15-353","article-title":"Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial","volume":"15","author":"Nunn","year":"2014","journal-title":"Trials"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2015-207245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:51:34Z","timestamp":1601099494000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2015-207245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,7]]},"references-count":75,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,10,14]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1136\/thoraxjnl-2015-207245"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207245","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,7]]}}}